OPICAPONE

OPICAPONE was reported 2446 times

OPICAPONE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 INFUSION SITE HYPERTROPHY 4 0.1429
1 DELUSIONAL DISORDER, JEALOUS TYPE 2 0.1429
2 DOPAMINE AGONIST WITHDRAWAL SYNDROME 7 0.1296
3 AEROPHOBIA 1 0.1250
4 PRODUCT REGIMEN CONFUSION 4 0.0769
5 STOMA SITE HYPERSENSITIVITY 2 0.0588
6 CORNEAL LACERATION 1 0.0556
7 BLOOD PRESSURE DIASTOLIC 1 0.0556
8 REDUCED FACIAL EXPRESSION 56 0.0552
9 INFUSION SITE PAPULE 5 0.0526
10 PORTAL VEIN CAVERNOUS TRANSFORMATION 2 0.0488
11 INFUSION SITE ABSCESS 22 0.0437
12 DYSKINESIA HYPERPYREXIA SYNDROME 2 0.0426
13 CREATINE KINASE ABNORMAL 1 0.0417
14 HYPERKINESIA 88 0.0415
15 ADJACENT SEGMENT DEGENERATION 1 0.0400
16 JEALOUS DELUSION 10 0.0353
17 ON AND OFF PHENOMENON 196 0.0353
18 DRUG THERAPEUTIC INCOMPATIBILITY 5 0.0325
19 ONYCHOMALACIA 4 0.0320
20 DYSDIADOCHOKINESIS 5 0.0292
21 PARKINSONIAN GAIT 18 0.0288
22 INSULIN C-PEPTIDE INCREASED 4 0.0288
23 INFUSION SITE INDURATION 42 0.0283
24 FREEZING PHENOMENON 96 0.0259
25 CEREBELLAR MICROHAEMORRHAGE 1 0.0256
26 ACTION TREMOR 4 0.0247
27 AKINESIA 50 0.0241
28 STOMA SITE RASH 2 0.0241
29 SALIVA ALTERED 21 0.0234
30 INFUSION SITE HAEMATOMA 11 0.0231
31 ABNORMAL ORGAN GROWTH 1 0.0227
32 TACITURNITY 2 0.0227
33 CATHETER SITE NODULE 4 0.0209
34 CATHETER SITE INDURATION 4 0.0207
35 TULARAEMIA 2 0.0206
36 DEEP BRAIN STIMULATION 12 0.0199
37 COPROLALIA 1 0.0175
38 ORGANIC BRAIN SYNDROME 3 0.0160
39 BEHAVIOURAL ADDICTION 1 0.0159
40 INFUSION SITE INFLAMMATION 11 0.0156
41 RESTING TREMOR 10 0.0155
42 BRADYKINESIA 90 0.0152
43 SALIVA DISCOLOURATION 5 0.0150
44 CATECHOLAMINES URINE INCREASED 1 0.0141
45 HYPERMOBILITY SYNDROME 7 0.0141
46 ENTERAL NUTRITION 8 0.0138
47 POSTURAL TREMOR 4 0.0137
48 CATHETER SITE MASS 2 0.0132
49 INTENTIONAL MEDICAL DEVICE REMOVAL BY PATIENT 13 0.0129
50 BLADDER SPHINCTER ATONY 2 0.0129
51 INCREASED DOSE ADMINISTERED 4 0.0128
52 CATHETER SITE DISCOMFORT 1 0.0125
53 CAMPTOCORMIA 3 0.0125
54 INFUSION SITE NODULE 12 0.0125
55 OPEN GLOBE INJURY 2 0.0121
56 DELUSIONAL DISORDER, UNSPECIFIED TYPE 9 0.0120
57 SPEECH SOUND DISORDER 2 0.0116
58 MEDICAL DEVICE SITE SWELLING 2 0.0116
59 SUSPICIOUSNESS 8 0.0114
60 EXPULSION OF MEDICATION 6 0.0113
61 BASE EXCESS INCREASED 1 0.0112
62 GASTRIC FISTULA 5 0.0112
63 LIMB IMMOBILISATION 2 0.0108
64 STOMA SITE INFLAMMATION 8 0.0107
65 STOMA SITE ERYTHEMA 19 0.0102
66 CATHETER SITE HAEMATOMA 3 0.0101
67 ADMINISTRATION SITE WOUND 1 0.0101
68 STOMA SITE DISCHARGE 27 0.0099
69 BUTTOCK INJURY 3 0.0098
70 GREATER TROCHANTERIC PAIN SYNDROME 2 0.0098
71 STOMA SITE HYPERGRANULATION 6 0.0095
72 HALLUCINATION, OLFACTORY 4 0.0092
73 STOMA SITE ODOUR 2 0.0089
74 CHOROID MELANOMA 1 0.0088
75 SUDDEN ONSET OF SLEEP 12 0.0086
76 ANAL PROLAPSE 1 0.0085
77 STOMA SITE INFECTION 11 0.0084
78 SLEEP ATTACKS 4 0.0084
79 DYSKINESIA 338 0.0083
80 INFUSION SITE MASS 9 0.0083
81 FOREIGN BODY IN GASTROINTESTINAL TRACT 3 0.0082
82 BLOOD URIC ACID DECREASED 4 0.0082
83 CATHETER SITE DISCOLOURATION 1 0.0082
84 BLOOD CATECHOLAMINES INCREASED 1 0.0080
85 STOMA SITE EXTRAVASATION 3 0.0078
86 SHORT STATURE 2 0.0076
87 BRIEF RESOLVED UNEXPLAINED EVENT 1 0.0076
88 INFUSION SITE CELLULITIS 4 0.0076
89 INFUSION SITE WARMTH 9 0.0073
90 IMPULSE-CONTROL DISORDER 15 0.0073
91 THERAPEUTIC PRODUCT EFFECT VARIABLE 28 0.0072
92 MERYCISM 2 0.0070
93 AVERSION 2 0.0069
94 FOOD REFUSAL 6 0.0069
95 MUSCLE RIGIDITY 82 0.0068
96 INFUSION SITE DISCHARGE 12 0.0068
97 INFUSION SITE REACTION 20 0.0067
98 HYPOKINESIA 97 0.0067
99 THERAPEUTIC PRODUCT EFFECT PROLONGED 3 0.0066
100 DEFIANT BEHAVIOUR 2 0.0065
101 ATTENTION-SEEKING BEHAVIOUR 1 0.0064
102 CHONDROSARCOMA 1 0.0063
103 MEDICAL DEVICE SITE DISCOMFORT 5 0.0062
104 CATHETER SITE WARMTH 1 0.0061
105 CATHETER SITE IRRITATION 2 0.0060
106 ENTEROSTOMY 2 0.0059
107 CATHETER SITE ABSCESS 1 0.0057
108 HALLUCINATION, VISUAL 116 0.0055
109 HYPERSEXUALITY 10 0.0055
110 STOMA SITE PAIN 8 0.0054
111 BIFASCICULAR BLOCK 1 0.0053
112 CATHETER SITE RELATED REACTION 4 0.0053
113 CATHETER SITE INFLAMMATION 3 0.0053
114 FAT TISSUE DECREASED 2 0.0051
115 CHEMICAL PERITONITIS 1 0.0051
116 HOUSEBOUND 2 0.0050
117 DISEASE RISK FACTOR 2 0.0050
118 DEVICE COLOUR ISSUE 2 0.0050
119 GRANULOCYTE COUNT INCREASED 2 0.0049
120 POSTURE ABNORMAL 16 0.0049
121 INFUSION SITE ERYTHEMA 41 0.0049
122 PRODUCT RESIDUE PRESENT 26 0.0048
123 DELUSION 74 0.0048
124 DYSTONIA 92 0.0047
125 OCULOMUCOCUTANEOUS SYNDROME 2 0.0047
126 HALLUCINATION 339 0.0045
127 NASAL OPERATION 3 0.0044
128 CEREBRAL MICROANGIOPATHY 1 0.0042
129 LANGUAGE DISORDER 9 0.0042
130 CALCIUM IONISED DECREASED 1 0.0041
131 DEPENDENCE ON OXYGEN THERAPY 2 0.0041
132 NEGATIVISM 3 0.0040
133 INFUSION SITE VESICLES 2 0.0038
134 FINE MOTOR SKILL DYSFUNCTION 11 0.0038
135 AMAUROSIS 3 0.0036
136 FEMORAL NECK FRACTURE 18 0.0035
137 FOLATE DEFICIENCY 4 0.0035
138 BLOOD 25-HYDROXYCHOLECALCIFEROL DECREASED 1 0.0034
139 CATHETER SITE CELLULITIS 1 0.0034
140 JAW OPERATION 3 0.0034
141 DEVICE ALARM ISSUE 6 0.0033
142 SITTING DISABILITY 2 0.0032
143 PNEUMOPERITONEUM 6 0.0032
144 INFUSION SITE BRUISING 7 0.0032
145 EXCESSIVE CERUMEN PRODUCTION 2 0.0032
146 REMISSION NOT ACHIEVED 2 0.0032
147 PERSECUTORY DELUSION 8 0.0032
148 IMMOBILE 14 0.0032
149 ANKLE DEFORMITY 1 0.0031
150 ABDOMINAL WALL ABSCESS 2 0.0031
151 C-REACTIVE PROTEIN DECREASED 2 0.0031
152 SUBCUTANEOUS EMPHYSEMA 3 0.0031
153 INFUSION SITE HAEMORRHAGE 10 0.0030
154 CEREBRAL AMYLOID ANGIOPATHY 1 0.0030
155 CATHETER SITE BRUISE 1 0.0030
156 FLUID INTAKE REDUCED 15 0.0030
157 PSYCHOTIC BEHAVIOUR 3 0.0030
158 CUBITAL TUNNEL SYNDROME 1 0.0029
159 BEZOAR 4 0.0029
160 INFUSION SITE DISCOMFORT 3 0.0029
161 FOREARM FRACTURE 2 0.0029
162 CIRCUMORAL OEDEMA 1 0.0029
163 COGWHEEL RIGIDITY 3 0.0029
164 HALLUCINATIONS, MIXED 12 0.0029
165 INVESTIGATION ABNORMAL 4 0.0028
166 DENTAL RESTORATION FAILURE 2 0.0028
167 BACTERIAL DISEASE CARRIER 2 0.0027
168 OBSTRUCTIVE SLEEP APNOEA SYNDROME 4 0.0027
169 DEMENTIA WITH LEWY BODIES 3 0.0027
170 CATHETER SITE DISCHARGE 3 0.0027
171 OESOPHAGEAL DISCOMFORT 2 0.0026
172 BASOPHIL COUNT INCREASED 2 0.0026
173 PRODUCT CLEANING INADEQUATE 7 0.0026
174 CERVICAL VERTEBRAL FRACTURE 9 0.0026
175 CREATINE KINASE INCREASED 2 0.0026
176 STOMA SITE HAEMORRHAGE 4 0.0026
177 INFUSION SITE INFECTION 6 0.0026
178 CARDIOVASCULAR SYMPTOM 1 0.0026
179 CLUMSINESS 7 0.0026
180 ORTHOSTATIC HYPOTENSION 44 0.0025
181 THERAPEUTIC PRODUCT EFFECT DELAYED 11 0.0024
182 BONE FISSURE 1 0.0024
183 INFUSION SITE PAIN 31 0.0024
184 INFUSION SITE IRRITATION 3 0.0023
185 THERAPEUTIC RESPONSE SHORTENED 77 0.0023
186 SOLILOQUY 2 0.0023
187 DEVICE LOOSENING 2 0.0023
188 CATHETER SITE PAIN 6 0.0023
189 SELF-DESTRUCTIVE BEHAVIOUR 2 0.0023
190 INFUSION SITE DISCOLOURATION 2 0.0023
191 CONGESTIVE HEPATOPATHY 1 0.0022
192 CATHETER SITE RASH 1 0.0022
193 TONGUE DRY 3 0.0022
194 CERUMEN IMPACTION 2 0.0022
195 TRAUMATIC INTRACRANIAL HAEMORRHAGE 2 0.0022
196 SMALL INTESTINAL PERFORATION 4 0.0021
197 DEVICE OCCLUSION 30 0.0021
198 JOINT DISLOCATION 22 0.0021
199 BLOOD BICARBONATE INCREASED 1 0.0021
200 PATIENT DISSATISFACTION WITH TREATMENT 4 0.0021
201 CORRECTIVE LENS USER 2 0.0021
202 BEHAVIOUR DISORDER 11 0.0020
203 MENTAL FATIGUE 3 0.0020
204 LUMBAR VERTEBRAL FRACTURE 9 0.0020
205 DELIRIUM 68 0.0020
206 DAYDREAMING 3 0.0019
207 DEVICE KINK 7 0.0019
208 RESPIRATORY TRACT IRRITATION 2 0.0019
209 ABDOMINAL INJURY 1 0.0019
210 CONSCIOUSNESS FLUCTUATING 2 0.0019
211 WALKING DISABILITY 4 0.0019
212 INFUSION SITE SWELLING 12 0.0019
213 COLITIS MICROSCOPIC 9 0.0019
214 ASPARTATE AMINOTRANSFERASE DECREASED 1 0.0019
215 CATHETER SITE ERYTHEMA 4 0.0019
216 OCULOGYRIC CRISIS 4 0.0019
217 TRAUMATIC HAEMATOMA 2 0.0019
218 PSYCHOTIC DISORDER 55 0.0019
219 SHOULDER FRACTURE 3 0.0018
220 ILLUSION 3 0.0018
221 BLOOD PH INCREASED 1 0.0018
222 DRUG EFFECT VARIABLE 2 0.0018
223 GAZE PALSY 3 0.0018
224 PELVIC ABSCESS 2 0.0017
225 ANOSMIA 25 0.0017
226 DEMENTIA 48 0.0017
227 MOVEMENT DISORDER 55 0.0017
228 AUTONOMIC NERVOUS SYSTEM IMBALANCE 5 0.0017
229 DISCOURAGEMENT 4 0.0017
230 HYPORESPONSIVE TO STIMULI 2 0.0017
231 TERMINAL INSOMNIA 3 0.0017
232 PNEUMONIA INFLUENZAL 2 0.0017
233 BRUXISM 9 0.0017
234 PANIC REACTION 12 0.0017
235 PNEUMOMEDIASTINUM 3 0.0017
236 FAECALOMA 9 0.0016
237 HYPERTENSIVE HEART DISEASE 3 0.0016
238 MOBILITY DECREASED 112 0.0016
239 DEVICE BATTERY ISSUE 1 0.0015
240 HALLUCINATION, AUDITORY 24 0.0015
241 CYSTITIS NONINFECTIVE 2 0.0015
242 ARTHROSCOPY 1 0.0015
243 PSYCHOTIC SYMPTOM 3 0.0015
244 NASAL DISCHARGE DISCOLOURATION 2 0.0014
245 PNEUMONIA ASPIRATION 36 0.0014
246 SUBILEUS 3 0.0014
247 JOINT INSTABILITY 2 0.0014
248 DEVICE CONNECTION ISSUE 3 0.0014
249 SLEEP DEFICIT 3 0.0014
250 TORTICOLLIS 3 0.0014
251 CERVICAL RADICULOPATHY 1 0.0014
252 JAW FRACTURE 3 0.0014
253 ALANINE AMINOTRANSFERASE DECREASED 1 0.0014
254 ACUTE ABDOMEN 2 0.0014
255 MEDICAL DEVICE DISCOMFORT 4 0.0013
256 SCOLIOSIS 8 0.0013
257 PARANOIA 22 0.0013
258 MOTOR DYSFUNCTION 13 0.0013
259 UPPER LIMB FRACTURE 25 0.0013
260 ABDOMINAL SYMPTOM 1 0.0012
261 AGGRESSION 62 0.0012
262 SLOW SPEECH 3 0.0012
263 SOMNAMBULISM 8 0.0012
264 DYSGRAPHIA 8 0.0012
265 SPINAL STENOSIS 5 0.0012
266 SUFFOCATION FEELING 3 0.0012
267 INJECTION SITE ABSCESS 3 0.0012
268 HYPERPARATHYROIDISM SECONDARY 3 0.0012
269 CONTRAINDICATED PRODUCT PRESCRIBED 2 0.0012
270 CRANIOFACIAL FRACTURE 1 0.0012
271 TRISMUS 6 0.0012
272 MEDICAL DEVICE REMOVAL 2 0.0012
273 GAIT INABILITY 38 0.0011
274 GASTRIC PERFORATION 3 0.0011
275 MEAN CELL HAEMOGLOBIN DECREASED 2 0.0011
276 SPEECH DISORDER 57 0.0011
277 ABULIA 1 0.0011
278 ADENOCARCINOMA GASTRIC 1 0.0011
279 INJECTION SITE CELLULITIS 2 0.0011
280 ANAL HAEMORRHAGE 3 0.0011
281 CATHETER SITE SWELLING 1 0.0011
282 GENERAL SYMPTOM 8 0.0011
283 WALKING AID USER 7 0.0011
284 DISORIENTATION 42 0.0011
285 HYPERCOAGULATION 2 0.0010
286 RESTLESSNESS 38 0.0010
287 BLADDER CATHETERISATION 1 0.0010
288 REHABILITATION THERAPY 4 0.0010
289 APPLICATION SITE BRUISE 1 0.0010
290 DEVICE POWER SOURCE ISSUE 3 0.0010
291 POOR QUALITY SLEEP 22 0.0010
292 ASPIRATION 11 0.0010
293 DYSPHAGIA 95 0.0010
294 SALIVARY HYPERSECRETION 10 0.0010
295 AUTONOMIC NEUROPATHY 1 0.0010
296 TREMOR 163 0.0010
297 DYSAESTHESIA 3 0.0010
298 INITIAL INSOMNIA 10 0.0010
299 BLADDER DYSFUNCTION 1 0.0010
300 CAROTID ARTERIOSCLEROSIS 1 0.0010
301 URINARY RETENTION 32 0.0010
302 MALABSORPTION 5 0.0010
303 LIVEDO RETICULARIS 2 0.0010
304 DYSARTHRIA 36 0.0010
305 FOREIGN BODY IN THROAT 3 0.0010
306 INFUSION SITE PRURITUS 3 0.0009
307 BALANCE DISORDER 82 0.0009
308 DRUG EFFECT LESS THAN EXPECTED 14 0.0009
309 COGNITIVE DISORDER 44 0.0009
310 BLOOD SODIUM ABNORMAL 1 0.0009
311 HYPOPHAGIA 24 0.0009
312 CEREBRAL ARTERY OCCLUSION 1 0.0009
313 HIP SURGERY 5 0.0009
314 TOOTH INJURY 4 0.0009
315 HYPERTHERMIA 7 0.0009
316 JAW DISORDER 5 0.0009
317 MANIA 15 0.0009
318 LIGAMENT SPRAIN 9 0.0009
319 PRODUCT COMMUNICATION ISSUE 8 0.0009
320 GASTROINTESTINAL ULCER 2 0.0009
321 SPINAL COLUMN INJURY 2 0.0009
322 TREATMENT NONCOMPLIANCE 49 0.0009
323 SUBSTANCE-INDUCED PSYCHOTIC DISORDER 2 0.0009
324 DRY THROAT 9 0.0009
325 ARTERIAL HAEMORRHAGE 1 0.0009
326 FALL 291 0.0009
327 FUNCTIONAL GASTROINTESTINAL DISORDER 3 0.0009
328 HYPOPNOEA 3 0.0009
329 BLADDER OPERATION 1 0.0009
330 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 61 0.0009
331 PATELLA FRACTURE 2 0.0009
332 UNRESPONSIVE TO STIMULI 22 0.0009
333 DEPRESSIVE SYMPTOM 3 0.0009
334 DISTURBANCE IN SOCIAL BEHAVIOUR 2 0.0008
335 SPINAL COMPRESSION FRACTURE 7 0.0008
336 SPUTUM DISCOLOURED 8 0.0008
337 DEVICE PLACEMENT ISSUE 3 0.0008
338 PULSE ABNORMAL 2 0.0008
339 DEVICE DISLOCATION 36 0.0008
340 SKIN LACERATION 9 0.0008
341 STARING 2 0.0008
342 GUILLAIN-BARRE SYNDROME 4 0.0008
343 CEREBRAL ARTERY EMBOLISM 1 0.0008
344 INFLAMMATORY MARKER INCREASED 4 0.0008
345 CONFUSIONAL STATE 130 0.0008
346 CATHETER SITE HAEMORRHAGE 2 0.0008
347 AORTIC VALVE REPLACEMENT 1 0.0008
348 FACE INJURY 3 0.0008
349 AGITATION 58 0.0008
350 PSYCHOMOTOR HYPERACTIVITY 13 0.0008
351 PHYSICAL DECONDITIONING 2 0.0008
352 ACTINIC KERATOSIS 2 0.0008
353 ABDOMINAL OPERATION 1 0.0008
354 PRODUCT PACKAGING DIFFICULT TO OPEN 2 0.0008
355 ANAEMIA POSTOPERATIVE 1 0.0008
356 PRODUCT USE COMPLAINT 12 0.0008
357 NEUROLEPTIC MALIGNANT SYNDROME 9 0.0008
358 SERUM FERRITIN INCREASED 4 0.0008
359 DEPRESSED MOOD 40 0.0008
360 CORONAVIRUS INFECTION 5 0.0008
361 BLOOD PRESSURE FLUCTUATION 18 0.0007
362 GAIT DISTURBANCE 143 0.0007
363 COMPRESSION FRACTURE 4 0.0007
364 DEVICE USE ISSUE 13 0.0007
365 NOCTURIA 9 0.0007
366 ABDOMINAL RIGIDITY 2 0.0007
367 SLEEP DISORDER 52 0.0007
368 DEVICE ISSUE 66 0.0007
369 DYSPHONIA 43 0.0007
370 ASPHYXIA 6 0.0007
371 CHOKING SENSATION 4 0.0007
372 NIGHTMARE 25 0.0007
373 PARKINSONISM 7 0.0007
374 THERAPEUTIC PRODUCT EFFECT DECREASED 32 0.0007
375 ENDOTRACHEAL INTUBATION 2 0.0007
376 SLEEP TERROR 3 0.0007
377 DUODENAL ULCER 5 0.0007
378 MICTURITION URGENCY 8 0.0007
379 TENSION HEADACHE 3 0.0007
380 NODULE 9 0.0007
381 LUMBAR SPINAL STENOSIS 2 0.0007
382 SEROTONIN SYNDROME 13 0.0007
383 APRAXIA 1 0.0007
384 PRODUCT PRESCRIBING ERROR 16 0.0007
385 POLYNEUROPATHY 8 0.0007
386 CRANIOCEREBRAL INJURY 2 0.0007
387 DEVICE PHYSICAL PROPERTY ISSUE 5 0.0007
388 PERSONALITY CHANGE 6 0.0006
389 PELVIC FRACTURE 5 0.0006
390 BLOOD CREATININE DECREASED 2 0.0006
391 SWELLING OF EYELID 4 0.0006
392 SKIN ABRASION 3 0.0006
393 FRACTURE 12 0.0006
394 RIB FRACTURE 13 0.0006
395 ABNORMAL BEHAVIOUR 25 0.0006
396 SCREAMING 4 0.0006
397 OBSESSIVE-COMPULSIVE DISORDER 5 0.0006
398 STUPOR 2 0.0006
399 PORTAL VEIN THROMBOSIS 2 0.0006
400 CARDIOVASCULAR INSUFFICIENCY 1 0.0006
401 KNEE OPERATION 6 0.0006
402 BEDRIDDEN 8 0.0006
403 EMBEDDED DEVICE 6 0.0006
404 RESTLESS LEGS SYNDROME 11 0.0006
405 SKIN MASS 4 0.0006
406 PLANTAR FASCIITIS 2 0.0006
407 PRODUCT PHYSICAL ISSUE 12 0.0006
408 SENSATION OF FOREIGN BODY 5 0.0006
409 EUPHORIC MOOD 6 0.0006
410 BLADDER NEOPLASM 1 0.0006
411 PRODUCT COLOUR ISSUE 3 0.0006
412 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 10 0.0006
413 CACHEXIA 3 0.0006
414 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 28 0.0006
415 MUSCULOSKELETAL STIFFNESS 51 0.0006
416 CHOREA 1 0.0006
417 ACUTE SINUSITIS 1 0.0006
418 ABNORMAL DREAMS 16 0.0006
419 BLOOD CHLORIDE INCREASED 1 0.0006
420 TACHYPHRENIA 2 0.0006
421 ORAL DISCOMFORT 8 0.0006
422 GENERAL PHYSICAL HEALTH DETERIORATION 66 0.0006
423 HANGOVER 2 0.0006
424 UNEVALUABLE EVENT 43 0.0006
425 BRONCHIOLITIS 2 0.0006
426 LOGORRHOEA 2 0.0006
427 CONTRAINDICATED PRODUCT ADMINISTERED 17 0.0006
428 AORTIC VALVE STENOSIS 1 0.0006
429 SUBDURAL HAEMATOMA 8 0.0006
430 BLOOD PRESSURE ABNORMAL 11 0.0006
431 INTENTIONAL UNDERDOSE 4 0.0005
432 NONSPECIFIC REACTION 3 0.0005
433 PNEUMONIA BACTERIAL 5 0.0005
434 URINARY INCONTINENCE 16 0.0005
435 CATHETER PLACEMENT 1 0.0005
436 HYPERACUSIS 2 0.0005
437 AURA 1 0.0005
438 NERVOUSNESS 28 0.0005
439 DEFORMITY 5 0.0005
440 IMPULSIVE BEHAVIOUR 2 0.0005
441 CATHETER SITE INFECTION 2 0.0005
442 UNINTENTIONAL MEDICAL DEVICE REMOVAL 6 0.0005
443 SOMNOLENCE 104 0.0005
444 PANIC DISORDER 2 0.0005
445 EPIGASTRIC DISCOMFORT 2 0.0005
446 MIOSIS 4 0.0005
447 TRIGEMINAL NEURALGIA 2 0.0005
448 BLOOD PRESSURE DECREASED 33 0.0005
449 CARDIAC DISCOMFORT 1 0.0005
450 FUNGAL SKIN INFECTION 2 0.0005
451 VITAMIN B12 DEFICIENCY 2 0.0005
452 HYPOTHERMIA 5 0.0005
453 INGUINAL HERNIA 3 0.0005
454 DRY MOUTH 40 0.0005
455 EYELID PTOSIS 5 0.0005
456 CONSTIPATION 107 0.0005
457 GOITRE 2 0.0005
458 THERAPY CESSATION 25 0.0005
459 CHEST INJURY 1 0.0005
460 SOCIAL PROBLEM 2 0.0005
461 AORTIC DISSECTION 2 0.0005
462 ILEUS 6 0.0005
463 DEPRESSED LEVEL OF CONSCIOUSNESS 19 0.0005
464 APATHY 7 0.0005
465 INCONTINENCE 5 0.0005
466 CARDIAC FAILURE CHRONIC 2 0.0005
467 ANAEMIA MACROCYTIC 1 0.0005
468 PRODUCT DISPENSING ISSUE 2 0.0005
469 TEARFULNESS 2 0.0005
470 DEREALISATION 1 0.0005
471 STAPHYLOCOCCAL BACTERAEMIA 2 0.0005
472 WOUND INFECTION 5 0.0005
473 INTENTIONAL DEVICE MISUSE 2 0.0005
474 TERMINAL STATE 3 0.0004
475 MALIGNANT MELANOMA 6 0.0004
476 MALNUTRITION 5 0.0004
477 ADENOCARCINOMA 1 0.0004
478 WRONG PRODUCT ADMINISTERED 3 0.0004
479 OROPHARYNGEAL DISCOMFORT 4 0.0004
480 ABNORMAL LOSS OF WEIGHT 3 0.0004
481 SENSORY DISTURBANCE 7 0.0004
482 RESPIRATION ABNORMAL 3 0.0004
483 EYE OPERATION 2 0.0004
484 UROSEPSIS 4 0.0004
485 MUSCLE TIGHTNESS 7 0.0004
486 ARTHRITIS INFECTIVE 2 0.0004
487 FEELING OF DESPAIR 2 0.0004
488 APPENDICITIS 4 0.0004
489 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 20 0.0004
490 TIBIA FRACTURE 2 0.0004
491 MUSCULOSKELETAL DISORDER 8 0.0004
492 LIMB DISCOMFORT 13 0.0004
493 SEDATION 11 0.0004
494 SUBCUTANEOUS ABSCESS 2 0.0004
495 WRIST FRACTURE 5 0.0004
496 LIMB OPERATION 2 0.0004
497 HUMERUS FRACTURE 2 0.0004
498 CHOKING 8 0.0004
499 THERAPY CHANGE 4 0.0004
500 SPINAL OPERATION 5 0.0004
501 CARTILAGE INJURY 1 0.0004
502 BLOOD PRESSURE SYSTOLIC ABNORMAL 1 0.0004
503 APHASIA 12 0.0004
504 DERMATOMYOSITIS 1 0.0004
505 ANGLE CLOSURE GLAUCOMA 1 0.0004
506 HYPONATRAEMIA 22 0.0004
507 ANXIETY 111 0.0004
508 ADVERSE DRUG REACTION 35 0.0004
509 BENIGN PROSTATIC HYPERPLASIA 2 0.0004
510 DIPLOPIA 10 0.0004
511 BRAIN FOG 6 0.0004
512 INCORRECT DOSE ADMINISTERED BY DEVICE 10 0.0004
513 SENSITIVITY TO WEATHER CHANGE 2 0.0004
514 FOOD CRAVING 2 0.0004
515 SARS-COV-2 TEST POSITIVE 5 0.0004
516 HYPOTHYROIDISM 12 0.0004
517 GASTROINTESTINAL MOTILITY DISORDER 2 0.0004
518 DECREASED ACTIVITY 4 0.0004
519 DECUBITUS ULCER 3 0.0004
520 TIC 2 0.0004
521 AKATHISIA 5 0.0004
522 FOOT DEFORMITY 4 0.0004
523 HOSPITALISATION 55 0.0004
524 HEAD INJURY 11 0.0003
525 EXERCISE TOLERANCE DECREASED 2 0.0003
526 MOUTH SWELLING 2 0.0003
527 PYELONEPHRITIS 3 0.0003
528 SOCIAL AVOIDANT BEHAVIOUR 2 0.0003
529 MADAROSIS 4 0.0003
530 PERIPHERAL SENSORY NEUROPATHY 2 0.0003
531 HIP FRACTURE 11 0.0003
532 SPINAL OSTEOARTHRITIS 3 0.0003
533 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 3 0.0003
534 CARDIAC PACEMAKER INSERTION 2 0.0003
535 FEAR 9 0.0003
536 SUICIDE ATTEMPT 20 0.0003
537 ATRIOVENTRICULAR BLOCK SECOND DEGREE 1 0.0003
538 DEVICE DELIVERY SYSTEM ISSUE 9 0.0003
539 TENSION 2 0.0003
540 DEVICE RELATED INFECTION 5 0.0003
541 DEVICE LEAKAGE 14 0.0003
542 MENTAL DISORDER 14 0.0003
543 NEPHROPATHY 3 0.0003
544 DEVICE BREAKAGE 13 0.0003
545 TARDIVE DYSKINESIA 9 0.0003
546 GASTRIC ULCER 6 0.0003
547 BLADDER PAIN 1 0.0003
548 INSOMNIA 83 0.0003
549 DIZZINESS POSTURAL 3 0.0003
550 INJECTION SITE INDURATION 4 0.0003
551 BRADYPHRENIA 2 0.0003
552 UNDERDOSE 22 0.0003
553 PRESCRIBED UNDERDOSE 6 0.0003
554 ANXIETY DISORDER 1 0.0003
555 URINARY TRACT INFECTION 51 0.0003
556 BLOOD UREA INCREASED 5 0.0003
557 WEIGHT DECREASED 83 0.0003
558 LOSS OF CONSCIOUSNESS 38 0.0003
559 POSTOPERATIVE WOUND INFECTION 2 0.0003
560 EPILEPSY 9 0.0003
561 EYE MOVEMENT DISORDER 2 0.0003
562 AUTOIMMUNE HAEMOLYTIC ANAEMIA 1 0.0003
563 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 59 0.0003
564 FEMUR FRACTURE 9 0.0003
565 RESPIRATORY DISTRESS 8 0.0003
566 MENTAL IMPAIRMENT 7 0.0003
567 AORTIC STENOSIS 1 0.0003
568 APHONIA 4 0.0003
569 CAROTID ARTERY STENOSIS 1 0.0003
570 SKIN REACTION 4 0.0003
571 BONE EROSION 1 0.0003
572 CONTUSION 27 0.0003
573 BLOOD CREATINE PHOSPHOKINASE INCREASED 8 0.0003
574 ABDOMINAL PAIN LOWER 7 0.0003
575 FAECES SOFT 2 0.0003
576 DYSURIA 10 0.0003
577 AMYLASE INCREASED 1 0.0003
578 PSYCHIATRIC SYMPTOM 2 0.0003
579 MEMORY IMPAIRMENT 37 0.0003
580 FEELING DRUNK 2 0.0003
581 CARDIAC DYSFUNCTION 1 0.0003
582 MIDDLE INSOMNIA 5 0.0003
583 RHABDOMYOLYSIS 11 0.0003
584 DERMATITIS CONTACT 3 0.0003
585 BOWEL MOVEMENT IRREGULARITY 2 0.0003
586 CLAVICLE FRACTURE 1 0.0003
587 LOWER LIMB FRACTURE 5 0.0003
588 HYPOTENSION 52 0.0003
589 APNOEA 2 0.0003
590 DEVICE DIFFICULT TO USE 17 0.0003
591 MOOD ALTERED 7 0.0003
592 CARDIOPULMONARY FAILURE 1 0.0003
593 HAEMATOCRIT DECREASED 5 0.0003
594 MACULAR DEGENERATION 3 0.0003
595 HYPERLIPIDAEMIA 3 0.0003
596 CEREBRAL ATROPHY 1 0.0003
597 NIGHT SWEATS 8 0.0002
598 INTENTIONAL SELF-INJURY 5 0.0002
599 SCHIZOPHRENIA 3 0.0002
600 BLOOD POTASSIUM INCREASED 4 0.0002
601 FEELING ABNORMAL 59 0.0002
602 DEPRESSION 56 0.0002
603 THERAPEUTIC RESPONSE UNEXPECTED 11 0.0002
604 RED BLOOD CELL COUNT DECREASED 7 0.0002
605 HYPERSOMNIA 7 0.0002
606 AGEUSIA 6 0.0002
607 HEMIPLEGIA 2 0.0002
608 SYNCOPE 24 0.0002
609 DRUG INTOLERANCE 23 0.0002
610 ASTHENIA 89 0.0002
611 CIRCULATORY COLLAPSE 4 0.0002
612 ARRHYTHMIA 11 0.0002
613 SKIN CANCER 5 0.0002
614 MYOPATHY 2 0.0002
615 BONE CANCER 1 0.0002
616 PRODUCT PRESCRIBING ISSUE 5 0.0002
617 URINE OUTPUT DECREASED 2 0.0002
618 HAND DEFORMITY 3 0.0002
619 INTERVERTEBRAL DISC PROTRUSION 5 0.0002
620 MALAISE 100 0.0002
621 GRIP STRENGTH DECREASED 2 0.0002
622 SOPOR 3 0.0002
623 HEAD DISCOMFORT 4 0.0002
624 BLOOD CREATINE INCREASED 1 0.0002
625 DRUG ERUPTION 4 0.0002
626 DIZZINESS 112 0.0002
627 LIMB INJURY 6 0.0002
628 TACHYPNOEA 3 0.0002
629 BLOOD THYROID STIMULATING HORMONE DECREASED 1 0.0002
630 C-REACTIVE PROTEIN INCREASED 8 0.0002
631 PNEUMONIA 71 0.0002
632 PERIPHERAL COLDNESS 3 0.0002
633 MUSCLE TWITCHING 5 0.0002
634 IRON DEFICIENCY ANAEMIA 2 0.0002
635 POLLAKIURIA 9 0.0002
636 CONJUNCTIVITIS 4 0.0002
637 PRODUCT DISTRIBUTION ISSUE 2 0.0002
638 DECREASED APPETITE 50 0.0002
639 THINKING ABNORMAL 4 0.0002
640 CARPAL TUNNEL SYNDROME 3 0.0002
641 BLINDNESS UNILATERAL 3 0.0002
642 LACERATION 2 0.0002
643 LEUKAEMIA 2 0.0002
644 PRODUCTIVE COUGH 10 0.0002
645 ANGINA PECTORIS 6 0.0002
646 INCREASED APPETITE 4 0.0002
647 AFFECT LABILITY 2 0.0002
648 ANGER 7 0.0002
649 CONDITION AGGRAVATED 62 0.0002
650 ILLNESS 21 0.0002
651 COUGH 57 0.0002
652 BREATH SOUNDS ABNORMAL 1 0.0002
653 DRUG INTERACTION 32 0.0002
654 DEVICE USE ERROR 7 0.0002
655 HYPOTONIA 2 0.0002
656 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 1 0.0002
657 CARDIOVASCULAR DISORDER 5 0.0002
658 DISCOMFORT 12 0.0002
659 SUBARACHNOID HAEMORRHAGE 2 0.0002
660 MUSCLE SPASMS 36 0.0002
661 SLUGGISHNESS 2 0.0002
662 FEELING HOT 12 0.0002
663 CEREBRAL HAEMORRHAGE 7 0.0002
664 ATRIAL FIBRILLATION 19 0.0002
665 EAR DISCOMFORT 2 0.0002
666 ERECTILE DYSFUNCTION 5 0.0002
667 HELICOBACTER INFECTION 2 0.0002
668 HYPERHIDROSIS 25 0.0002
669 TEMPERATURE INTOLERANCE 2 0.0002
670 SKELETAL INJURY 2 0.0002
671 PERITONITIS 4 0.0002
672 HAEMATOMA 5 0.0002
673 TOOTH LOSS 4 0.0002
674 NERVOUS SYSTEM DISORDER 6 0.0002
675 BLOOD LACTIC ACID INCREASED 1 0.0002
676 ABSCESS 3 0.0002
677 BODY HEIGHT DECREASED 2 0.0002
678 SUICIDAL IDEATION 17 0.0002
679 ALTERED STATE OF CONSCIOUSNESS 4 0.0002
680 BACK DISORDER 3 0.0002
681 SEPTIC SHOCK 8 0.0002
682 PERIPHERAL SWELLING 28 0.0002
683 DEAFNESS UNILATERAL 1 0.0002
684 DRUG LEVEL INCREASED 3 0.0002
685 HAEMOPTYSIS 5 0.0002
686 WOUND 5 0.0002
687 CELLULITIS 9 0.0002
688 UPPER GASTROINTESTINAL HAEMORRHAGE 3 0.0002
689 ACUTE PULMONARY OEDEMA 1 0.0002
690 HEMIPARESIS 3 0.0002
691 STATUS EPILEPTICUS 2 0.0002
692 FLATULENCE 10 0.0002
693 CHOLECYSTECTOMY 2 0.0002
694 DEATH 150 0.0002
695 NEOPLASM 2 0.0002
696 DEVICE DEFECTIVE 3 0.0002
697 DYSSTASIA 5 0.0002
698 SPINAL PAIN 2 0.0002
699 COVID-19 PNEUMONIA 2 0.0002
700 CATARACT OPERATION 1 0.0002
701 CATARACT 10 0.0002
702 CHOLECYSTITIS 2 0.0002
703 DISTURBANCE IN ATTENTION 9 0.0002
704 PRODUCT USE ISSUE 31 0.0002
705 HYPOGLYCAEMIA 8 0.0002
706 CYTOPENIA 2 0.0002
707 SMALL INTESTINAL OBSTRUCTION 2 0.0002
708 CHOLANGITIS 1 0.0002
709 HEPATIC STEATOSIS 3 0.0002
710 TOOTH EXTRACTION 2 0.0002
711 HYPERTENSION 34 0.0002
712 SECRETION DISCHARGE 2 0.0002
713 BACK PAIN 37 0.0002
714 BLEPHAROSPASM 1 0.0002
715 INJECTION SITE IRRITATION 2 0.0002
716 C-REACTIVE PROTEIN ABNORMAL 1 0.0002
717 SEIZURE 18 0.0002
718 ROTATOR CUFF SYNDROME 2 0.0002
719 CARDIAC FLUTTER 1 0.0002
720 HIATUS HERNIA 2 0.0002
721 HAEMORRHOIDS 3 0.0002
722 RESPIRATORY TRACT INFECTION 4 0.0002
723 FATIGUE 119 0.0002
724 ASPERGILLUS INFECTION 1 0.0002
725 INFECTION 22 0.0002
726 ARTERIOSCLEROSIS CORONARY ARTERY 1 0.0002
727 APPETITE DISORDER 1 0.0002
728 ADVERSE REACTION 2 0.0002
729 BLOOD PRESSURE INCREASED 23 0.0002
730 CARDIAC FAILURE ACUTE 1 0.0001
731 SKIN DISORDER 5 0.0001
732 SPINAL FRACTURE 3 0.0001
733 ATRIOVENTRICULAR BLOCK COMPLETE 1 0.0001
734 JOINT RANGE OF MOTION DECREASED 2 0.0001
735 ILL-DEFINED DISORDER 9 0.0001
736 THROAT TIGHTNESS 4 0.0001
737 HYPOAESTHESIA 22 0.0001
738 IMPAIRED GASTRIC EMPTYING 2 0.0001
739 TACHYCARDIA 13 0.0001
740 CARDIO-RESPIRATORY ARREST 6 0.0001
741 ROAD TRAFFIC ACCIDENT 6 0.0001
742 MASS 2 0.0001
743 COVID-19 25 0.0001
744 DEHYDRATION 19 0.0001
745 HEART RATE DECREASED 5 0.0001
746 OXYGEN SATURATION DECREASED 8 0.0001
747 PRODUCT DOSE OMISSION IN ERROR 4 0.0001
748 IMPAIRED QUALITY OF LIFE 2 0.0001
749 LETHARGY 8 0.0001
750 DYSPNOEA 78 0.0001
751 CRYING 5 0.0001
752 CARDIAC FAILURE 11 0.0001
753 CHEST DISCOMFORT 14 0.0001
754 PAIN IN EXTREMITY 40 0.0001
755 CEREBRAL DISORDER 1 0.0001
756 ARTHROPOD BITE 1 0.0001
757 PULMONARY OEDEMA 6 0.0001
758 GASTROINTESTINAL DISORDER 12 0.0001
759 THROAT IRRITATION 6 0.0001
760 CHROMATURIA 3 0.0001
761 HOT FLUSH 10 0.0001
762 HYPOAESTHESIA ORAL 2 0.0001
763 INTESTINAL OBSTRUCTION 5 0.0001
764 PRODUCT DOSE OMISSION ISSUE 39 0.0001
765 MUSCULAR WEAKNESS 15 0.0001
766 PRODUCT AVAILABILITY ISSUE 3 0.0001
767 AORTIC ANEURYSM 1 0.0001
768 DEVICE FAILURE 2 0.0001
769 ABDOMINAL DISCOMFORT 22 0.0001
770 HIP ARTHROPLASTY 2 0.0001
771 CEREBROVASCULAR ACCIDENT 22 0.0001
772 ANKLE FRACTURE 2 0.0001
773 CONGENITAL ANOMALY 1 0.0001
774 CONCUSSION 1 0.0001
775 VISUAL IMPAIRMENT 16 0.0001
776 BASAL CELL CARCINOMA 2 0.0001
777 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 23 0.0001
778 HAEMATOCHEZIA 7 0.0001
779 HAEMOGLOBIN DECREASED 13 0.0001
780 BLOOD ALBUMIN DECREASED 1 0.0001
781 ULCER 2 0.0001
782 SCIATICA 2 0.0001
783 ATRIAL FLUTTER 1 0.0001
784 NECK PAIN 7 0.0001
785 ENCEPHALOPATHY 3 0.0001
786 FUNGAL INFECTION 4 0.0001
787 SURGERY 7 0.0001
788 PYREXIA 40 0.0001
789 CARDIAC MURMUR 1 0.0001
790 GASTRITIS 3 0.0001
791 PAIN 70 0.0001
792 COLD SWEAT 2 0.0001
793 BRADYCARDIA 6 0.0001
794 DYSPEPSIA 11 0.0001
795 NAUSEA 88 0.0001
796 ANAL INCONTINENCE 1 0.0001
797 FREQUENT BOWEL MOVEMENTS 3 0.0001
798 PALPITATIONS 13 0.0001
799 BLOOD THYROID STIMULATING HORMONE INCREASED 1 0.0001
800 VOMITING 51 0.0001
801 DYSGEUSIA 8 0.0001
802 BACTERIAL INFECTION 2 0.0001
803 SWELLING 10 0.0001
804 HEPATIC CIRRHOSIS 2 0.0001
805 PHOTOPHOBIA 2 0.0001
806 ARTERIOSCLEROSIS 1 0.0001
807 PAIN IN JAW 3 0.0001
808 BLOOD URINE PRESENT 2 0.0001
809 INTENTIONAL DOSE OMISSION 3 0.0001
810 FEELING JITTERY 2 0.0001
811 SLEEP APNOEA SYNDROME 2 0.0001
812 GLAUCOMA 2 0.0001
813 ATELECTASIS 1 0.0001
814 ERUCTATION 2 0.0001
815 PRESCRIBED OVERDOSE 2 0.0001
816 INTENTIONAL PRODUCT MISUSE 9 0.0001
817 ACUTE MYOCARDIAL INFARCTION 3 0.0001
818 DRUG INEFFECTIVE 134 0.0001
819 BLADDER DISORDER 1 0.0001
820 IRRITABILITY 6 0.0001
821 BLOOD POTASSIUM DECREASED 3 0.0001
822 BRAIN INJURY 1 0.0001
823 PRODUCT ADMINISTRATION ERROR 2 0.0001
824 ABDOMINAL PAIN 23 0.0001
825 FEEDING DISORDER 2 0.0001
826 TASTE DISORDER 2 0.0001
827 OEDEMA PERIPHERAL 12 0.0001
828 VERTIGO 6 0.0001
829 EMOTIONAL DISORDER 3 0.0001
830 ERYTHEMA 20 0.0001
831 PARAESTHESIA 15 0.0001
832 KNEE ARTHROPLASTY 2 0.0001
833 PULMONARY EMBOLISM 9 0.0001
834 BRONCHITIS 7 0.0001
835 OSTEOARTHRITIS 4 0.0001
836 CLOSTRIDIUM DIFFICILE COLITIS 1 0.0001
837 MYALGIA 16 0.0001
838 EATING DISORDER 2 0.0001
839 CHILLS 11 0.0001
840 JOINT INJURY 2 0.0001
841 INCORRECT DOSE ADMINISTERED 21 0.0001
842 ACUTE KIDNEY INJURY 14 0.0001
843 EXPIRED PRODUCT ADMINISTERED 3 0.0001
844 LIP SWELLING 3 0.0001
845 INFLUENZA 10 0.0001
846 SKIN IRRITATION 4 0.0001
847 THROMBOSIS 7 0.0001
848 HYPERKALAEMIA 3 0.0001
849 HYPOXIA 3 0.0001
850 CARDIAC ARREST 7 0.0001
851 ATAXIA 1 0.0001
852 BACTERAEMIA 1 0.0001
853 COMA 4 0.0001
854 ANAEMIA 16 0.0001
855 ACCIDENT 1 0.0001
856 PANIC ATTACK 3 0.0001
857 NEURALGIA 2 0.0001
858 CEREBRAL INFARCTION 2 0.0001
859 EXTRAPYRAMIDAL DISORDER 2 0.0001
860 VISION BLURRED 11 0.0001
861 DERMATITIS ALLERGIC 1 0.0001
862 BRAIN OEDEMA 1 0.0001
863 OVERDOSE 17 0.0001
864 FLUSHING 8 0.0001
865 FLUID RETENTION 4 0.0001
866 INTENTIONAL OVERDOSE 5 0.0001
867 OFF LABEL USE 68 0.0001
868 AMNESIA 5 0.0001
869 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 4 0.0001
870 BLOOD CREATININE INCREASED 5 0.0001
871 ECZEMA 4 0.0001
872 JOINT STIFFNESS 2 0.0001
873 GASTROOESOPHAGEAL REFLUX DISEASE 6 0.0001
874 EXTRA DOSE ADMINISTERED 3 0.0001
875 PALLOR 2 0.0001
876 ACUTE HEPATIC FAILURE 1 0.0001
877 OSTEOPOROSIS 3 0.0001
878 RESPIRATORY ARREST 2 0.0001
879 MENTAL STATUS CHANGES 2 0.0001
880 FEELING COLD 2 0.0001
881 WITHDRAWAL SYNDROME 3 0.0001
882 BLOOD TEST ABNORMAL 1 0.0001
883 TOXICITY TO VARIOUS AGENTS 12 0.0001
884 CHEST PAIN 13 0.0001
885 THERAPY INTERRUPTED 5 0.0001
886 HERPES ZOSTER 4 0.0001
887 PANCREATIC CARCINOMA 2 0.0001
888 COMPLICATION ASSOCIATED WITH DEVICE 1 0.0001
889 BONE LOSS 1 0.0001
890 THERAPEUTIC RESPONSE DECREASED 4 0.0001
891 TINNITUS 3 0.0001
892 ADVERSE EVENT 6 0.0001
893 HYPOKALAEMIA 3 0.0001
894 SWOLLEN TONGUE 2 0.0001
895 CYANOSIS 1 0.0001
896 DIARRHOEA 41 0.0001
897 CYSTITIS 2 0.0001
898 MOOD SWINGS 2 0.0001
899 DEEP VEIN THROMBOSIS 4 0.0001
900 CHOLELITHIASIS 2 0.0001
901 STAPHYLOCOCCAL INFECTION 2 0.0001
902 HEADACHE 38 0.0001
903 HEART RATE INCREASED 6 0.0001
904 DRY EYE 3 0.0001
905 COMPLETED SUICIDE 5 0.0001
906 NEOPLASM MALIGNANT 4 0.0001
907 RENAL IMPAIRMENT 5 0.0001
908 CANDIDA INFECTION 1 0.0001
909 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 2 0.0001
910 INFLAMMATION 3 0.0001
911 JOINT SWELLING 7 0.0001
912 EMOTIONAL DISTRESS 7 0.0001
913 ABDOMINAL DISTENSION 6 0.0001
914 HAEMORRHAGE 6 0.0001
915 DEVICE MALFUNCTION 4 0.0001
916 INJURY 4 0.0001
917 ACUTE RESPIRATORY DISTRESS SYNDROME 1 0.0001
918 INJECTION SITE ERYTHEMA 7 0.0001
919 PRODUCT ADHESION ISSUE 2 0.0001
920 HYPERGLYCAEMIA 2 0.0001
921 BONE DISORDER 1 0.0001
922 RESPIRATORY FAILURE 4 0.0001
923 BLOOD GLUCOSE ABNORMAL 1 0.0001
924 ARTHROPATHY 3 0.0001
925 SEPSIS 6 0.0001
926 ABDOMINAL PAIN UPPER 11 0.0001
927 DYSPNOEA EXERTIONAL 2 0.0001
928 BLOOD SODIUM DECREASED 1 0.0001
929 CHRONIC KIDNEY DISEASE 4 0.0001
930 WHITE BLOOD CELL COUNT INCREASED 2 0.0001
931 ACUTE RESPIRATORY FAILURE 1 0.0001
932 BLOOD PRESSURE SYSTOLIC INCREASED 1 0.0001
933 DRUG DOSE OMISSION BY DEVICE 4 0.0001
934 DISEASE PROGRESSION 6 0.0001
935 WHEEZING 3 0.0001
936 ARTHRALGIA 21 0.0001
937 INJECTION SITE BRUISING 4 0.0001
938 BODY TEMPERATURE INCREASED 1 0.0000
939 PRODUCT USE IN UNAPPROVED INDICATION 12 0.0000
940 GASTROINTESTINAL HAEMORRHAGE 4 0.0000
941 HYPOACUSIS 2 0.0000
942 CLOSTRIDIUM DIFFICILE INFECTION 1 0.0000
943 NEPHROLITHIASIS 2 0.0000
944 INJECTION SITE REACTION 3 0.0000
945 SKIN DISCOLOURATION 2 0.0000
946 NASOPHARYNGITIS 8 0.0000
947 RENAL DISORDER 2 0.0000
948 BURNING SENSATION 3 0.0000
949 CARDIAC DISORDER 4 0.0000
950 NEUROPATHY PERIPHERAL 4 0.0000
951 BLOOD GLUCOSE DECREASED 2 0.0000
952 LUNG DISORDER 2 0.0000
953 WEIGHT INCREASED 9 0.0000
954 INJECTION SITE SWELLING 3 0.0000
955 MUSCULOSKELETAL PAIN 2 0.0000
956 ARTHRITIS 3 0.0000
957 BREAST CANCER FEMALE 1 0.0000
958 CARDIAC FAILURE CONGESTIVE 3 0.0000
959 OEDEMA 2 0.0000
960 DRUG ABUSE 3 0.0000
961 MEDICATION ERROR 2 0.0000
962 EYE PAIN 2 0.0000
963 PRODUCT SUBSTITUTION ISSUE 2 0.0000
964 NASAL CONGESTION 2 0.0000
965 STOMATITIS 2 0.0000
966 PLEURAL EFFUSION 2 0.0000
967 OROPHARYNGEAL PAIN 3 0.0000
968 RHINORRHOEA 2 0.0000
969 DEVICE EXPULSION 2 0.0000
970 SWELLING FACE 2 0.0000
971 ACCIDENTAL OVERDOSE 1 0.0000
972 EPISTAXIS 2 0.0000
973 BLOOD GLUCOSE INCREASED 5 0.0000
974 COLITIS 1 0.0000
975 PRURITUS 10 0.0000
976 ALOPECIA 5 0.0000
977 BLINDNESS 1 0.0000
978 URTICARIA 4 0.0000
979 SKIN EXFOLIATION 2 0.0000
980 DRUG WITHDRAWAL SYNDROME 2 0.0000
981 ANGIOEDEMA 1 0.0000
982 RENAL FAILURE 3 0.0000
983 HYPERSENSITIVITY 4 0.0000
984 BREAST CANCER 2 0.0000
985 MIGRAINE 2 0.0000
986 WHITE BLOOD CELL COUNT DECREASED 2 0.0000
987 MYOCARDIAL INFARCTION 3 0.0000
988 BLADDER CANCER 1 0.0000
989 DRY SKIN 2 0.0000
990 PRODUCT QUALITY ISSUE 2 0.0000
991 RASH 5 0.0000
992 INJECTION SITE PAIN 2 0.0000